The role of clinical in vivo 1H-MR spectroscopy in the evaluation of epilepsies

Spectroscopy

Volumn 16, Issue 3-4, 2002, Pages 297-306

  Hammen, T ^a   Stefan, H ^a   Tomandl, B ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; DIAGNOSIS; METABOLITES; NEUROLOGY;

ANTIEPILEPTIC TREATMENT;

SPECTROSCOPIC ANALYSIS;

ARTICLE; IN VIVO STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSTOPERATIVE PERIOD; PREDICTION; TEMPORAL LOBE EPILEPSY;

EID: 0036962501     PISSN: 07124813     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/842843     Document Type: Article

References (26)

1. Jw. Hugg, K.D. Laxter, G.B. Matson, A.A. Maudsley and W.M. Weiner, Neuron loss localises human focal epilepsy by in vivo proton MR spectroscopic imaging, Ann. Neurol. 34 (1993), 788-794.
2. F. Cendes, F. Andermann, M.C. Preul and D.L. Arnold, Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images, Ann. Neurol. 35(2) (1994), 211-216.
3. F. Cendes, Z. Caramano, F. Andermann, F. Dubeau and D.L. Arnold, Proton magnetic resonance spectroscopic imaging and magnetic resonance imaging volumetry in the lateraliszation of temporal lobe epilepsy: a series of 100 patients, Ann. Neurolog. 42 (1997), 737-746.
4. A. Conelly, G.D. Jackson, J.S. Duncan, M.D. King and D.G. Gadian, Magnetic resonance spectroscopy in temporal lobe epilepsy, Neurology 44 (1994), 1411-1417.
5. R. Kuzniezky, J.W. Hugg, H. Hetherington, E. Butterworth, E. Bilir, E. Faught and F. Gilliam, Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy, Neurology 51(1) (1998), 66-71.
6. R. Kuzniecky, J.W. Hugg, H. Hetherington and F. Gilliam, Predictive value of 1H-MRSI for outcome in temporal lobectomy, Neurology 53(4) (1999) 694-708.
7. D.F. Gadian, A. Conelly, J.S. Duncan et al., H-magnetic resonance spectroscopy in the investigation of intractable epilepsy, Acta Neurol. Scand. 152(Suppl.) (1994), 116-121.
8. J.H. Cross, A. Connelly, G.D. Jackson, C.L. Johnson, G.R. Neville and D.G. Gadian, Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy, Ann. Neurol. 39 (1996), 107-113.
9. I. Constandinitis, J.A. Malko, S.B. Petermann et al., Evaluation of 1H magnetic resonance spectroscopic imaging as a diagnostic tool for the lateralization of epileptogenic seizure foci, Br. J. Radiol. 69(817) (1996), 15-24.
10. R.C. Knowlton, K.D. Laxer, G. Ende et al., Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy, Ann. Neurol. 42 (1997), 829-837.
11. J.H. Margerison and J.A.N. Corsellis, Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathologic study of the brain in epilepsy with particular reference to the temporal lobes, Brain 89 (1966), 499.
12. P. Vermathen, G. Ende, K.D. Laxer, R.C. Knowlton, G.B. Matson and M.W. Weiner, Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy, Ann. Neurol. 42(2) (1997), 194-199.
13. F. Cendes, F. Andermann and D.L. Arnold, Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging, Neurology 49(6) (1997), 1525-1533.
14. R. Kuzniecky, Ch. Palmer, J. Hugg and R. Knowlton, Magnetic resonance spectroscopic imaging in TLE: Neuronal dysfunction or cell loss, Arch. Neurol. 58 (2001), 2048-2053.
15. T.L. Babb, Pathological substrates of epilepsy, in: E. Wylie et al. eds, The Treatment of Epilepsy: Principles and Practice, Lea and Febiger, Philadelphia, PA, 1993, pp. 55-70. A.N. Corsellis, The incidence of Ammons Horn sclerosis, Brain 80 (1957), 193-203.
16. T.L. Babb, Pathological substrates of epilepsy, in: E. Wylie et al. eds, The Treatment of Epilepsy: Principles and Practice, Lea and Febiger, Philadelphia, PA, 1993, pp. 55-70. A.N. Corsellis, The incidence of Ammons Horn sclerosis, Brain 80 (1957), 193-203.
17. W. Van Paesschen, S. Sisodiya and A. Conelly, Quantitative hippocampal MRI and intractable temporal lobe epilepsy, Neurology 45 (1995) 2233-2240.
18. K.E. Eberhardt, H. Stefan, M., B.F. Tomandl et al., The significance of bilateral CSI changes for the postoperative outcome in temporal lobe epilepsy, Journal of Computer Assisted Tomography 24(6), 919-926.
19. H. Stefan, E. Pauli, K.E. Eberhardt, I. Schafer, P. Hopp and W.J. Huk, MR-Spektroskopie, T2 relaxometry and postoperative prognosis in cryptogenic temporal lobe epilepsy, Nervenarzt 71(4) (2001), 282-287.
20. H. Stefan, K.E. Eberhardt, M. Huk et al., Diagnostic imaging in refractory temporal lobe epilepsy. A comparison of MR volumetry and multivoxel-MR-spectroscopy for assessment of postoperative prognosis, Nervenarzt 72(2) (2001), 103-105.
21. R. Kuzniezky, J. Hugg, H. Hetherington, R. Martin, E. Faught, R. Morawetz and F. Gilliam, Predictive value of 1H-MRSI for outcome in temporal lobectomy, Neurology 53(4) (1999), 694-698.
22. L.M. Li, F. Cendes, S.B. Antel, F. Andermann, W. Serles, F. Dubeau, A. Olivier and D.L. Arnold, Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilpesy and bilateral hippocampal atrophy, Ann. Neurol. 47(2) (2000), 195-200.
23. O.A. Petroff, D.L. Rothmann, K.L. Behar, T.L. Collins and R.H. Mattson, Human brain GABA levels rise rapidly after initation of vigabatrin therapy, Neurology 47(6) (1996), 1567-1571.
24. O.A. Petroff, R.H. Mattson, K.L. Behar, F. Hyder and D.L. Rothmann, Vigabatrin increases human brain homocarnosine and improves seizure control, Ann. Neurol. 44(6) (1996), 948-952.
25. S.G. Mueller, O.M. Weber, C.O. Duc, B. Weber, D. Meier W. Russ, P. Boesiger and H.G. Wieser, Effects of Vigabatrin on brain GABA+/Cr signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder charachteristics, Epilepsia 42(1) (2001), 29-40.
26. O.A. Petroff, F. Hyder, R.H. Mattson and D.L. Rothman, Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy, Neurology 52(3) (1999), 473-478.